Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Elite provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Scleroderma.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Elite provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Elite provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Dermatomyositis, Myositis, Scleroderma, and Polymyositis.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Melody Chung is a Rheumatologist in Baltimore, Maryland. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis.

Pravitt Gourh is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Gourh is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Caffey Disease, and Arthritis.

Sam Serafi is a Rheumatologist in Baltimore, Maryland. Dr. Serafi is rated as an Advanced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Donald Thomas is a Rheumatologist in Greenbelt, Maryland. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, and Osteoporosis. Dr. Thomas is currently accepting new patients.

Douglas Lienesch is an Internal Medicine specialist and a Rheumatologist in Elkton, Maryland. Dr. Lienesch is rated as an Advanced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Sjogren Syndrome, Necrotizing Vasculitis, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and IgG4-Related Disease.

Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica. Dr. Hauptman is currently accepting new patients.

Yevgeniy Sheyn is a Rheumatologist in Clinton, Maryland. Dr. Sheyn is rated as an Experienced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Fibromyalgia, Gout, Vitamin D Deficiency, and Tenosynovitis. Dr. Sheyn is currently accepting new patients.

Maria Chou is a Rheumatologist in Clinton, Maryland. Dr. Chou is rated as an Experienced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Gout, Rheumatoid Arthritis (RA), Bursitis, and Tenosynovitis. Dr. Chou is currently accepting new patients.

Rukmini Konatalapalli is a Rheumatologist in Greenbelt, Maryland. Dr. Konatalapalli is rated as an Experienced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Gout, Fibromyalgia, Rheumatoid Arthritis (RA), and Bursitis. Dr. Konatalapalli is currently accepting new patients.

Seema Patel is a Rheumatologist in Baltimore, Maryland. Dr. Patel has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Rheumatoid Arthritis (RA), and Discoid Lupus Erythematosus (DLE).

Tazeen Rehman is a Rheumatologist in Baltimore, Maryland. Dr. Rehman is rated as an Experienced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia.

Rachel Wallwork is a Rheumatologist in Baltimore, Maryland. Dr. Wallwork is rated as an Advanced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), IgG4-Related Disease, and Scleroma. Dr. Wallwork is currently accepting new patients.

Steven Hsu, M.D., is a member of the Johns Hopkins Medicine Division of Cardiology, specializing in heart failure, mechanical circulatory support, and cardiac transplantation. Dr. Hsu received his undergraduate degree from Yale College followed by his medical degree from the Johns Hopkins University School of Medicine. He completed intern and residency training in internal medicine at the Johns Hopkins Hospital, where he also served as an Assistant Chief of Service for the Osler Medical Service. He then completed a clinical fellowship in cardiology and a post-doctoral fellowship in advanced heart failure/transplant at Hopkins. He is a faculty member of the American College of Cardiology. He sees patients with heart failure, mechanical circulatory support devices such as left ventricular assist devices, and cardiac transplants. In addition to caring for patients, Dr. Hsu runs an NIH R01-funded research lab studying the hemodynamic and cellular changes related to right ventricular failure in the setting of pulmonary hypertension and heart failure. Dr. Hsu is rated as an Advanced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Pulmonary Hypertension, Heart Failure, Hypertension, Cardiomyopathy, and Heart Transplant.

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is rated as an Advanced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis.

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Advanced provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc).